Analgesic Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee.
Phase of Trial: Phase III
Latest Information Update: 16 Jun 2011
At a glance
- Drugs Naproxcinod; Naproxen
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Adverse reactions; Pharmacodynamics; Registrational; Therapeutic Use
- Sponsors NicOx
- 23 Jul 2010 FDA does not approve NDA according to a media release from NICOX.
- 03 May 2010 Undisclosed results from a pre-specified pooled analysis of the 301, 302 and 303 naproxcinod studies were presented at ASH 2010, according to a NicOx media release. The abstract has been published in the Journal of Clinical Hypertension 2010, 12 (s1), A5.
- 01 May 2010 Prespecified pooled pharmacodynamic analysis presented at the 25th Annual Scientific Meeting of the American Society of Hypertension.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History